In patients with chronic kidney disease (CKD) there is a high prevalence of gastrointestinal disorders and negative changes in the microbiota and assimilation of nutrients, which is associated with an increased risk of morbidity and mortality.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Gastrointestinal symptoms
Timeframe: baseline intervention and 1.5 months
Renal function
Timeframe: Baseline intervention and one and a half months